Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
about
Controversies in targeted therapy of adult T cell leukemia/lymphoma: ON target or OFF target effects?Involvement of glutathione as a mechanism of indirect protection against spontaneous ex vivo apoptosis associated with bovine leukemia virus.An antiviral peptide targets a coiled-coil domain of the human T-cell leukemia virus envelope glycoprotein.Emodin and DHA potently increase arsenic trioxide interferon-alpha-induced cell death of HTLV-I-transformed cells by generation of reactive oxygen species and inhibition of Akt and AP-1Multiple Pathways Control the Reactivation of Telomerase in HTLV-I-Associated Leukemia.Proapoptotic regimes for HTLV-I-transformed cells: targeting Tax and the NF-kappaB pathway.Inhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells.The combination of arsenic, interferon-alpha, and zidovudine restores an "immunocompetent-like" cytokine expression profile in patients with adult T-cell leukemia lymphoma.Gene expression profiling of ATL patients: compilation of disease-related genes and evidence for TCF4 involvement in BIRC5 gene expression and cell viabilityC-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity.Animal models on HTLV-1 and related viruses: what did we learn?Using antimicrobial adjuvant therapy in cancer treatment: a review.Efficacy and mechanism of action of the proteasome inhibitor PS-341 in T-cell lymphomas and HTLV-I associated adult T-cell leukemia/lymphoma.N-(4-hydroxyphenyl)retinamide induces growth arrest and apoptosis in HTLV-I-transformed cells.Dichotomy of all-trans retinoic acid inducing signals for adult T-cell leukemia.A novel medium-throughput biological assay system for HTLV-1 infectivity and drug discovery.Inhibition of mammalian target of rapamycin signaling by everolimus induces senescence in adult T-cell leukemia/lymphoma and apoptosis in peripheral T-cell lymphomas.Reactive oxygen species mediate N-(4-hydroxyphenyl)retinamide-induced cell death in malignant T cells and are inhibited by the HTLV-I oncoprotein Tax.
P2860
Q26852683-52BF697A-F555-4800-959F-B8D08A1B6FAAQ34192859-F7134152-6607-4A69-8F29-35D12B28CEC5Q34756124-9E3BB925-CDA5-453A-BD98-09A7A56A2718Q35628873-D6DE1F39-65FE-401F-A93D-D75281D3923BQ36104368-544FC4B6-6587-463D-AE53-BBE592D727FCQ36104480-A5C28C6E-EE86-4CF6-ABF8-DFD065200DCCQ36424037-A27C0993-DE9E-49B8-BA99-8F7F31C99079Q37116770-06FF9C2A-901F-4F5A-B827-8128CEF3A8E4Q37169145-C627E2D2-33AE-4221-B0CE-884404BED992Q37424824-94630D70-ACA4-4D51-B6AB-8CA617425D1CQ38050763-32A70B2C-6BB5-445A-AC15-CE2769939C7BQ38060894-826C627C-5653-4F14-A6E5-D4598F1BABECQ40492153-0F8940C0-4C71-4A02-A002-329F5076F22EQ40601214-9C6282D6-4E03-4843-A851-A8C9C21F42AEQ46448334-5F0A6217-3B9C-4D28-8536-E5FA899CF481Q47100549-4F9230C5-D4D0-4E73-A064-3FDF28E919CBQ53290255-B8846559-1D41-4BF2-8235-57E615BA8E53Q55239415-7EB79BA4-7E42-405A-8BC6-94A41AAE50E0
P2860
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
description
2001 nî lūn-bûn
@nan
2001 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
@ast
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
@en
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
@nl
type
label
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
@ast
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
@en
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
@nl
prefLabel
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
@ast
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
@en
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives.
@nl
P1433
P1476
Treatment of adult T-cell leukaemia/lymphoma: current strategy and future perspectives
@en
P2093
Bazarbachi A
P356
10.1016/S0168-1702(01)00286-6
P577
2001-10-01T00:00:00Z